Verdence Capital Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,715
Closed -$361K 658
2025
Q3
$361K Buy
15,715
+1,059
+7% +$23.6K 0.02% 541
2025
Q2
$333K Buy
14,656
+465
+3% +$11K 0.02% 527
2025
Q1
$430K Buy
+14,191
New +$541K 0.03% 437
2024
Q4
Sell
-4,664
Closed -$296K 634
2024
Q3
$296K Buy
4,664
+1,152
+33% +$83.2K 0.02% 523
2024
Q2
$237K Buy
+3,512
New +$245K 0.02% 536

Other funds holding ACHC

Verdence Capital Advisors's ACHC Position: Q4 2025 in Review

Verdence Capital Advisors sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 15,715 shares — an estimated $361K sold.

Verdence Capital Advisors first reported a position in ACHC in Q2 2024 and held it in 5 quarters. The position peaked at $430K in Q1 2025. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

  • Verdence Capital Advisors reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
  • Verdence Capital Advisors sold 15,715 Acadia Healthcare shares in Q4 2025, an estimated $361K.
  • Verdence Capital Advisors first reported a position in Acadia Healthcare in Q2 2024 and held it in 5 quarters.
  • Verdence Capital Advisors's Acadia Healthcare position peaked at $430K in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Verdence Capital Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.